droxidopa

Generic: droxidopa

Labeler: novadoz pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name droxidopa
Generic Name droxidopa
Labeler novadoz pharmaceuticals llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

droxidopa 300 mg/1

Manufacturer
Novadoz Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 72205-074
Product ID 72205-074_e30e4875-830c-48ed-a6ee-0bddcceece84
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211741
Listing Expiration 2027-12-31
Marketing Start 2021-02-19

Pharmacologic Class

Chemical Structure
catecholamines [cs]
Physiologic Effect
increased blood pressure [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72205074
Hyphenated Format 72205-074

Supplemental Identifiers

RxCUI
1490026 1490034 1490038
UPC
0372205072053 0372205074903 0372205073050 0372205074057 0372205072909 0372205073906
UNII
J7A92W69L7
NUI
M0003647 N0000178478

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name droxidopa (source: ndc)
Generic Name droxidopa (source: ndc)
Application Number ANDA211741 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 500 CAPSULE in 1 BOTTLE (72205-074-05)
  • 90 CAPSULE in 1 BOTTLE (72205-074-90)
source: ndc

Packages (2)

Ingredients (1)

droxidopa (300 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e30e4875-830c-48ed-a6ee-0bddcceece84", "openfda": {"nui": ["M0003647", "N0000178478"], "upc": ["0372205072053", "0372205074903", "0372205073050", "0372205074057", "0372205072909", "0372205073906"], "unii": ["J7A92W69L7"], "rxcui": ["1490026", "1490034", "1490038"], "spl_set_id": ["381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d"], "pharm_class_cs": ["Catecholamines [CS]"], "pharm_class_pe": ["Increased Blood Pressure [PE]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE in 1 BOTTLE (72205-074-05)", "package_ndc": "72205-074-05", "marketing_start_date": "20210219"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (72205-074-90)", "package_ndc": "72205-074-90", "marketing_start_date": "20210219"}], "brand_name": "Droxidopa", "product_id": "72205-074_e30e4875-830c-48ed-a6ee-0bddcceece84", "dosage_form": "CAPSULE", "pharm_class": ["Catecholamines [CS]", "Increased Blood Pressure [PE]"], "product_ndc": "72205-074", "generic_name": "Droxidopa", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Droxidopa", "active_ingredients": [{"name": "DROXIDOPA", "strength": "300 mg/1"}], "application_number": "ANDA211741", "marketing_category": "ANDA", "marketing_start_date": "20210219", "listing_expiration_date": "20271231"}